Traditional Chinese medicine leader Yuyantang finds tonic in aging population
The company has filed for a Hong Kong IPO, thriving on China’s growing silver economy and a steady stream of government policies supporting traditional Chinese medicine Key Takeaways: Yuyantang has…
Gushengtang steps up TCM buying spree, doubling down in Beijing
The healthcare company has announced five acquisitions in the past two weeks to shore up growth and fend off competition in the traditional Chinese medicine market Key Takeaways: Gushengtang is…
Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
The company will use a majority of the $68 million it raised from its Hong Kong listing to expand its network of traditional Chinese medicine hospitals and clinics Key Takeaways:…
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
One of China’s oldest medical names has applied to list its Tong Ren Tang Healthcare Investment unit, which is building an integrated healthcare system Key Takeaways: Top-rated non-public traditional Chinese…
Chinese medicine firm seeks elusive elixir of IPO success
The healthcare services arm of the Tong Ren Tang group enjoys a high-profile TCM brand, but its profit margins lag far behind industry peers Key Takeaways: Tong Ren Tang Healthcare…
Anew Health taps investor ‘Qi’ with Nasdaq listing plan
The Hong Kong-based provider of pain relief services using traditional Chinese principles aims to raise about $7.2 million through its U.S. listing, valuing it at up to $200 million Key…
Baiyunshan serves up high dividend in lieu of vanilla results
Profits from the company’s Great Health segment rose 14% in the first half of 2025, primarily driven by strong results for its popular Wanglaoji herbal tea Key Takeaways: Baiyunshan’s revenue…
Recent Articles
RELATED ARTICLES
-
Tong Ren Tang kicks off IPO leveraging time-honored medicinal brand to offer healthcare
2667.HK
- Tong Ren Tang Healthcare makes trading debut, backed by 39% annual patient growth
-
JBM Healthcare gets bitter pill from investors on anemic performance
2161.HK
- Gushengtang steps up TCM buying spree, doubling down in Beijing
- Investors flee Yan Palace as aging brand struggles to find new audience
-
Confined to Hong Kong, Lung Fung lacks tonic for growth-hungry investors
2290.HK
